Showing results (171-180 of 3,343) with videos related to

Sort By:
Pageof 335
Journal of Neurosurgery|July 5, 2011
Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled studyNing Lin, Ian F Dunn, Michael Glantz, et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2025
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's diseaseMilan Fiala, Bruce D Hammock, Sung Hee Hwang, et al.
North Carolina Medical Journal|October 28, 2024
A Health Care Clinical Data Platform for Rapid Deployment of Artificial Intelligence and Machine Learning Algorithms for Cancer Care and Oncology Clinical TrialsSoma Sengupta, Rohan Rao, Zachary Kaufman, et al.
Annual Review of Marine Science|February 19, 2011
Estuarine and coastal ocean carbon paradox: CO2 sinks or sites of terrestrial carbon incineration?Wei-Jun Cai
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|February 4, 2015
[The current status and prospect of laparoscopic hepatectomy]Xiu-Jun Cai
Oncotarget|May 4, 2017
IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65Shruti Bhargava, Abhirami Visvanathan, Vikas Patil, et al.
The Journal of Clinical Investigation|August 5, 2008
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteinsDavid S Ziegler, Renee D Wright, Santosh Kesari, et al.
Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.
Oncotarget|November 10, 2016
RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeuticsFlorian J Sulzmaier, Shirley Young-Robbins, Pengfei Jiang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 15, 2015
Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform TechnologyStuart Ibsen, Avery Sonnenberg, Carolyn Schutt, et al.
Pageof 335